Mereo BioPharma Group plc (MAH0) - Total Liabilities

Latest as of December 2025: €5.00 Million EUR ≈ $5.85 Million USD

Based on the latest financial reports, Mereo BioPharma Group plc (MAH0) has total liabilities worth €5.00 Million EUR (≈ $5.85 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Mereo BioPharma Group plc to evaluate the company's liquid asset resilience ratio.

Mereo BioPharma Group plc - Total Liabilities Trend (2016–2025)

This chart illustrates how Mereo BioPharma Group plc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Mereo BioPharma Group plc.

Mereo BioPharma Group plc Competitors by Total Liabilities

The table below lists competitors of Mereo BioPharma Group plc ranked by their total liabilities.

Company	Country	Total Liabilities
Pelat Timah Nusantara Tbk JK:NIKL	Indonesia	Rp57.12 Million
Western Alaska Minerals Corp V:WAM	Canada	CA$6.35 Million
Xreality Group Ltd AU:XRG	Australia	AU$37.23 Million
Jet2 PLC LSE:JET2	UK	GBX4.21 Billion
Singsongholdin KO:006880	Korea	₩165.62 Billion
Mount Logan Capital Inc. Common Stock NASDAQ:MLCI	USA	$1.49 Billion
Kim Hin Industry Bhd KLSE:5371	Malaysia	RM104.34 Million
Nordic Mining ASA OL:NOM	Norway	Nkr2.32 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Mereo BioPharma Group plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Mereo BioPharma Group plc balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	10.46	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.12	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mereo BioPharma Group plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mereo BioPharma Group plc (2016–2025)

The table below shows the annual total liabilities of Mereo BioPharma Group plc from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	€5.00 Million ≈ $5.85 Million	-67.57%
2024-12-31	€15.42 Million ≈ $18.03 Million	-3.39%
2023-12-31	€15.96 Million ≈ $18.66 Million	-39.10%
2022-12-31	€26.21 Million ≈ $30.64 Million	-31.77%
2021-12-31	€38.41 Million ≈ $44.91 Million	-50.70%
2020-12-31	€77.92 Million ≈ $91.09 Million	+68.68%
2019-12-31	€46.19 Million ≈ $54.00 Million	+33.87%
2018-12-31	€34.51 Million ≈ $40.34 Million	+1.93%
2017-12-31	€33.85 Million ≈ $39.58 Million	+350.87%
2016-12-31	€7.51 Million ≈ $8.78 Million	--

About Mereo BioPharma Group plc

F:MAH0 Germany Biotechnology

Market Cap

$45.91 Million

€39.27 Million EUR

Market Cap Rank

#23652 Global

#2055 in Germany

Share Price

€0.25

Change (1 day)

+8.85%

52-Week Range

€0.20 - €1.96

All Time High

€4.48